Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Reduction of cardiovascular risk with icosapent ethyl (Vascepa).

[No authors listed]

Med Lett Drugs Ther. 2020 Feb 10;62(1591):17-18. No abstract available.

PMID:
32022786
2.

Human growth hormone level decreased in women aged <60 years but increased in men aged >50 years.

Wang X, Wang S, Wu H, Jiang M, Xue H, Zhu Y, Wang C, Zha X, Wen Y.

Medicine (Baltimore). 2020 Jan;99(2):e18440. doi: 10.1097/MD.0000000000018440.

3.
4.

Investigational drugs in development for hypertriglyceridemia: a coming-of-age story.

Rhainds D, Brodeur MR, Tardif JC.

Expert Opin Investig Drugs. 2019 Dec;28(12):1059-1079. doi: 10.1080/13543784.2019.1696772. Review.

PMID:
31752565
5.

Recent developments in pharmacotherapy for hypertriglyceridemia: what's the current state of the art?

Florentin M, Kostapanos MS, Anagnostis P, Liamis G.

Expert Opin Pharmacother. 2020 Jan;21(1):107-120. doi: 10.1080/14656566.2019.1691523. Epub 2019 Nov 18. Review.

PMID:
31738617
6.

The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study.

Shang J, Yu D, Cai Y, Wang Z, Zhao B, Zhao Z, Simmons D.

Medicine (Baltimore). 2019 Nov;98(46):e17995. doi: 10.1097/MD.0000000000017995.

7.

Risk factors for the development of hyperuricemia: A STROBE-compliant cross-sectional and longitudinal study.

Ni Q, Lu X, Chen C, Du H, Zhang R.

Medicine (Baltimore). 2019 Oct;98(42):e17597. doi: 10.1097/MD.0000000000017597.

8.

EPA and DHA have divergent effects on serum triglycerides and lipogenesis, but similar effects on lipoprotein lipase activity: a randomized controlled trial.

Klingel SL, Metherel AH, Irfan M, Rajna A, Chabowski A, Bazinet RP, Mutch DM.

Am J Clin Nutr. 2019 Dec 1;110(6):1502-1509. doi: 10.1093/ajcn/nqz234.

PMID:
31535138
9.

Baseline Triglyceride Level Affected the Efficacy of Vildagliptin in Treating Type 2 Diabetes: A Post Hoc Analysis of the VISION Study.

Zhou L, Cai X, Luo Y, Zhang F, Ji L.

J Diabetes Res. 2019 Aug 8;2019:9347132. doi: 10.1155/2019/9347132. eCollection 2019.

10.

Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality.

Taylor MK, Swerdlow RH, Sullivan DK.

Nutrients. 2019 Aug 15;11(8). pii: E1910. doi: 10.3390/nu11081910. Review.

11.

Effects of medium chain triglycerides on body fat distribution and adipocytokine levels in children with acute lymphoblastic leukemia under chemotherapy.

Zhang R, Chen J, Zheng H, Li Y, Huang H, Liang Z, Jiang H, Sun J.

Medicine (Baltimore). 2019 Aug;98(33):e16811. doi: 10.1097/MD.0000000000016811.

12.

Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients.

Toth PP, Philip S, Hull M, Granowitz C.

Mayo Clin Proc. 2019 Sep;94(9):1670-1680. doi: 10.1016/j.mayocp.2019.03.028. Epub 2019 Aug 9.

13.

ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors.

Kegulian NC, Ramms B, Horton S, Trenchevska O, Nedelkov D, Graham MJ, Lee RG, Esko JD, Yassine HN, Gordts PLSM.

Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2145-2156. doi: 10.1161/ATVBAHA.119.312723. Epub 2019 Aug 8.

PMID:
31390883
14.

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.

Witztum JL, Gaudet D, Freedman SD, Alexander VJ, Digenio A, Williams KR, Yang Q, Hughes SG, Geary RS, Arca M, Stroes ESG, Bergeron J, Soran H, Civeira F, Hemphill L, Tsimikas S, Blom DJ, O'Dea L, Bruckert E.

N Engl J Med. 2019 Aug 8;381(6):531-542. doi: 10.1056/NEJMoa1715944.

PMID:
31390500
15.

Serum Uric Acid and Triglycerides in Chinese Patients with Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study.

Ma W, Cui C, Feng S, Li G, Han G, Hu Y, Li X, Lv J, Liu C, Jin F.

Biomed Res Int. 2019 Jul 2;2019:9792412. doi: 10.1155/2019/9792412. eCollection 2019.

16.

Medium-chain triglycerides (8:0 and 10:0) are promising nutrients for sarcopenia: a randomized controlled trial.

Abe S, Ezaki O, Suzuki M.

Am J Clin Nutr. 2019 Sep 1;110(3):652-665. doi: 10.1093/ajcn/nqz138.

PMID:
31334544
17.

Food Intake and Satiety Response after Medium-Chain Triglycerides Ingested as Solid or Liquid.

Maher T, Sampson A, Goslawska M, Pangua-Irigaray C, Shafat A, Clegg ME.

Nutrients. 2019 Jul 17;11(7). pii: E1638. doi: 10.3390/nu11071638.

18.

Cardiovascular Disease Risk Across a Spectrum of Adverse Plasma Lipid Combinations by Gender and Glycemic Status.

Liu X, Yang Y, Kang F, Li J, Zhou M, Ma X, Yu T, Zhang T, Xue F.

Am J Cardiol. 2019 Sep 1;124(5):702-708. doi: 10.1016/j.amjcard.2019.05.058. Epub 2019 Jun 6.

PMID:
31311663
19.

Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care.

da Silva A, Caldas APS, Hermsdorff HHM, Bersch-Ferreira ÂC, Torreglosa CR, Weber B, Bressan J.

Cardiovasc Diabetol. 2019 Jul 11;18(1):89. doi: 10.1186/s12933-019-0893-2.

20.

Mechanisms of lipid droplet biogenesis.

Chapman KD, Aziz M, Dyer JM, Mullen RT.

Biochem J. 2019 Jul 9;476(13):1929-1942. doi: 10.1042/BCJ20180021. Review.

PMID:
31289128

Supplemental Content

Loading ...
Support Center